CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer
Author
A Giatromanolaki
AF Wahl
+45Â more
C Hennequin
CP Belani
DC Betticher
DH Johnson
DJ Glover
DV Skarlos
F Geuritte Voegelein
G Retalis
H Choy
J Brugarolas
JE Mollman
JH Yan
JST Sham
LC Pronk
M Froudarakis
M Graff de
M I Koukourakis
M Koukourakis
MA Bookman
MA Bookman
MI Koukourakis
MI Koukourakis
MJ Bent van den
MJ McKeage
MJ Millward
ML Patchen
MV Blagosklonny
N Bahlitzanakis
P Francis
P Fumoleau
PA Bunn
PH Hilkens
PZ New
RE Langley
RG Hoop van der
RL Capizzi
S Haldar
S Kalokyris
SW Low
T Giannakakis
TC Shea
TH Wang
V Georgoulias
WF Morgan
World Health Organisation
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref